Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine
- Status
- TERMINATED
- Phase
- PHASE2
FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants
- Status
- COMPLETED
- Phase
- PHASE4